News & AnalysisMedilink inks $50m Series AMedilink, a Chinese biotech company, has secured $50 million in Series A financing.ByIris Dorbian1 March 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs